Unknown

Dataset Information

0

Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.


ABSTRACT: The COVID-19 pandemic caused by SARS-CoV-2 infection is spreading at an alarming rate and has created an unprecedented health emergency around the globe. There is no effective vaccine or approved drug treatment against COVID-19 and other pathogenic coronaviruses. The development of antiviral agents is an urgent priority. Biochemical events critical to the coronavirus replication cycle provided a number of attractive targets for drug development. These include, spike protein for binding to host cell-surface receptors, proteolytic enzymes that are essential for processing polyproteins into mature viruses, and RNA-dependent RNA polymerase for RNA replication. There has been a lot of ground work for drug discovery and development against these targets. Also, high-throughput screening efforts have led to the identification of diverse lead structures, including natural product-derived molecules. This review highlights past and present drug discovery and medicinal-chemistry approaches against SARS-CoV, MERS-CoV and COVID-19 targets. The review hopes to stimulate further research and will be a useful guide to the development of effective therapies against COVID-19 and other pathogenic coronaviruses.

SUBMITTER: Ghosh AK 

PROVIDER: S-EPMC7264561 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.

Ghosh Arun K AK   Brindisi Margherita M   Shahabi Dana D   Chapman Mackenzie E ME   Mesecar Andrew D AD  

ChemMedChem 20200507 11


The COVID-19 pandemic caused by SARS-CoV-2 infection is spreading at an alarming rate and has created an unprecedented health emergency around the globe. There is no effective vaccine or approved drug treatment against COVID-19 and other pathogenic coronaviruses. The development of antiviral agents is an urgent priority. Biochemical events critical to the coronavirus replication cycle provided a number of attractive targets for drug development. These include, spike protein for binding to host c  ...[more]

Similar Datasets

| S-EPMC7323606 | biostudies-literature
| S-EPMC10074736 | biostudies-literature
| 2346925 | ecrin-mdr-crc
| S-EPMC7228277 | biostudies-literature
| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC4393377 | biostudies-other
| S-EPMC7263008 | biostudies-literature
| S-EPMC8372206 | biostudies-literature
| S-EPMC7803792 | biostudies-literature
2010-06-05 | E-GEOD-546 | biostudies-arrayexpress